Figure 1.

Frequency of reported adverse effects after intake of placebo (white bars) or MPH1 (black bars) or MPH2 (grey bars) for 4 weeks; * significantly different from placebo, P < 0.05.

Boelsma and Kloek Nutrition Journal 2010 9:52   doi:10.1186/1475-2891-9-52
Download authors' original image